Cargando…

Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD

Mostrar otras versiones (1)

Lack of dystrophin expression is the underlying genetic basis for Duchenne muscular dystrophy (DMD). However, disease severity varies between patients, based on specific genetic modifiers. D2-mdx is a model for severe DMD that exhibits exacerbated muscle degeneration and failure to regenerate even i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mázala, Davi A. G., Hindupur, Ravi, Moon, Young Jae, Shaikh, Fatima, Gamu, Iteoluwakishi H., Alladi, Dhruv, Panci, Georgiana, Weiss-Gayet, Michèle, Chazaud, Bénédicte, Partridge, Terence A., Novak, James S., Jaiswal, Jyoti K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319851/ https://www.ncbi.nlm.nih.gov/pubmed/37402716 http://dx.doi.org/10.1038/s41420-023-01503-0

Ejemplares similares

Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD
por: Mázala, Davi A. G., et al.
Publicado: (2023)

Macrophages Improve Survival, Proliferation and Migration of Engrafted Myogenic Precursor Cells into MDX Skeletal Muscle
por: Lesault, Pierre-François, et al.
Publicado: (2012)

Myogenic Reprogramming of Bone Marrow Derived Cells in a W(41)Dmd(mdx) Deficient Mouse Model
por: Walsh, Stuart, et al.
Publicado: (2011)

Humanizing the mdx mouse model of DMD: the long and the short of it
por: Yucel, Nora, et al.
Publicado: (2018)

Greater Colo-Rectal Activation Phenotype in Exercised mdx Mice
por: Nearing, Marie, et al.
Publicado: (2018)

Author Correction: Humanizing the mdx mouse model of DMD: the long and the short of it
por: Yucel, Nora, et al.
Publicado: (2020)

Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients
por: Vitiello, Libero, et al.
Publicado: (2018)

Ventilatory Chemosensory Drive Is Blunted in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2013)

Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmd(mdx) rat model
por: Caudal, Dorian, et al.
Publicado: (2020)

Coping with the calcium overload caused by cell injury: ER to the rescue
por: Chandra, Goutam, et al.
Publicado: (2021)

“Of Mice and Measures”: A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic: First Workshop Report: Examining current findings and opportunities around the emerging D2.B10-Dmd(mdx)/J (D2/mdx) model in context of the classic C57BL/10ScSn-Dmd(mdx)/J (Bl10/mdx)
por: Gordish-Dressman, Heather, et al.
Publicado: (2018)

Cardiovascular phenotype of the Dmd(mdx) rat – a suitable animal model for Duchenne muscular dystrophy
por: Szabó, Petra Lujza, et al.
Publicado: (2021)

Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients
por: Rossi, Rachele, et al.
Publicado: (2021)

Interrogation of Dystrophin and Dystroglycan Complex Protein Turnover After Exon Skipping Therapy
por: Novak, James S., et al.
Publicado: (2021)

Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD
por: Górecki, Dariusz C.
Publicado: (2022)

Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD
por: Akpulat, Ugur, et al.
Publicado: (2018)

What Can We Learn From Clinical Trials of Exon Skipping for DMD?
por: Lu, Qi-long, et al.
Publicado: (2014)

Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse
por: Wang, Derek W., et al.
Publicado: (2018)

Hematopoietic Prostaglandin D Synthase Inhibitor PK007 Decreases Muscle Necrosis in DMD mdx Model Mice
por: Yarlagadda, Sai, et al.
Publicado: (2021)

Tetraploidization of Immortalized Myoblasts Induced by Cell Fusion Drives Myogenic Sarcoma Development with DMD Deletion
por: Merle, Candice, et al.
Publicado: (2020)

Characterization of the Cardiac Structure and Function of Conscious D2.B10-Dmd(mdx)/J (D2-mdx) mice from 16–17 to 24–25 Weeks of Age
por: De Giorgio, Daria, et al.
Publicado: (2023)

Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations
por: Luce, Leonela N., et al.
Publicado: (2016)

Dmd(mdx)/Large(myd): a new mouse model of neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies
por: Martins, Poliana C. M., et al.
Publicado: (2013)

Human muscle stem cells are refractory to aging
por: Novak, James S., et al.
Publicado: (2021)

Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse
Publicado: (1990)

Matrix Metalloproteinase-9 Inhibition Improves Proliferation and Engraftment of Myogenic Cells in Dystrophic Muscle of mdx Mice
por: Hindi, Sajedah M., et al.
Publicado: (2013)

The expression of myogenic regulatory factors and muscle growth factors in the masticatory muscles of dystrophin-deficient (MDX) mice
por: Spassov, Alexander, et al.
Publicado: (2011)

Sertoli Cells Improve Myogenic Differentiation, Reduce Fibrogenic Markers, and Induce Utrophin Expression in Human DMD Myoblasts
por: Salvadori, Laura, et al.
Publicado: (2021)

Serotonin and Histamine Therapy Increases Tetanic Forces of Myoblasts, Reduces Muscle Injury, and Improves Grip Strength Performance of Dmd(mdx) Mice
por: Gurel, Volkan, et al.
Publicado: (2015)

DMD & BMD – CLINICAL: P.51 DMD Hub: demonstrating impact for DMD trials
por: Heslop, E., et al.
Publicado: (2020)

Notch Stimulates Both Self-Renewal and Lineage Plasticity in a Subset of Murine CD9(High) Committed Megakaryocytic Progenitors
por: Weiss-Gayet, Michèle, et al.
Publicado: (2016)

Preserved Left Ventricular Function despite Myocardial Fibrosis and Myopathy in the Dystrophin-Deficient D2.B10-Dmd(mdx)/J Mouse
por: Hayes, Holly M., et al.
Publicado: (2022)

Single-cell transcriptomic analysis of the identity and function of fibro/adipogenic progenitors in healthy and dystrophic muscle
por: Uapinyoying, Prech, et al.
Publicado: (2023)

Adipose-derived stem cells enhance myogenic differentiation in the mdx mouse model of muscular dystrophy via paracrine signaling
por: Cao, Ji-qing, et al.
Publicado: (2016)

Endoplasmic reticulum maintains ion homeostasis required for plasma membrane repair
por: Chandra, Goutam, et al.
Publicado: (2021)

Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
por: Duddy, William, et al.
Publicado: (2015)

PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD)
por: Sengupta, Kasturi, et al.
Publicado: (2020)

Exon skipping for DMD
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2012)

Pseudoexons of the DMD Gene
por: Keegan, Niall P.
Publicado: (2020)

The dual CCR2/CCR5 chemokine receptor antagonist Cenicriviroc reduces macrophage infiltration and disease severity in Duchenne muscular dystrophy (Dmd(mdx-4Cv)) mice
por: Liang, Feng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_povc3etdv9q6t2l3ut5i2htqao